Clinical Trial Update: Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dihydroartemisinin-piperaquine or sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anemia has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Sickle Cell Anemia in Children

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Liverpool School of Tropical Medicine | Conditions: Sickle Cell Anemia in Children, Malaria | Phase 3 | Status: COMPLETED